{
    "clinical_study": {
        "@rank": "74067", 
        "brief_summary": {
            "textblock": "This study will attempt to determine the best time to begin a smoking cessation program in\n      individuals who undergo intensive treatment for alcohol dependence.  The goal of this trial\n      is to determine whether a smoking cessation program is more effective if it occurs at the\n      same time as or after treatment for alcohol dependence.  The study also will attempt to\n      determine the effect of smoking cessation programs on the outcome of treatment for alcohol\n      dependence."
        }, 
        "brief_title": "Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch)", 
        "completion_date": {
            "#text": "January 2004", 
            "@type": "Actual"
        }, 
        "condition": [
            "Alcoholism", 
            "Smoking"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Alcoholism", 
                "Smoking"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Meets criteria for alcohol use disorder and other drug dependence.\n\n          -  Complete first week of alcohol treatment program.\n\n          -  Current cigarette smoker (more than 5 cigarettes/day, smoking more than 1 year).\n\n        Exclusion Criteria:\n\n          -  Lifetime diagnosis of an excluding psychiatric disorder: bipolar disorder,\n             schizophrenia or other psychotic disorder, panic disorder with or without\n             agoraphobia, obsessive-compulsive disorder, generalized anxiety disorder, eating\n             disorder, post- traumatic stress disorder, antisocial personality disorder, or\n             borderline personality disorder.\n\n          -  Unable to participate in protocol due to functional deficits or severe depression.\n\n          -  Suicidal or homicidal ideation.\n\n          -  Current use of disulfiram (Antabuse) or naltrexone (Revia).\n\n          -  Current use of pipes, cigars, or smokeless tobacco and unwillingness to stop.\n\n          -  Lives more than 100 miles from alcohol treatment facility.\n\n          -  No telephone."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": "500", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000444", 
            "org_study_id": "NIAAAJOS11124", 
            "secondary_id": "R01AA011124"
        }, 
        "intervention": {
            "intervention_name": "nicotine replacement patch", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Nicotine", 
                "Nicotine polacrilex"
            ]
        }, 
        "lastchanged_date": "February 10, 2011", 
        "location": {
            "facility": {
                "address": {
                    "city": "Minneapolis", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55417"
                }, 
                "name": "General Internal Medicine, VA Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Timing of Smoking Intervention in Alcohol Treatment", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2004", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000444"
        }, 
        "source": "Minneapolis Veterans Affairs Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute on Alcohol Abuse and Alcoholism (NIAAA)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Minneapolis Veterans Affairs Medical Center", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "September 1997", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2008"
    }, 
    "geocoordinates": {
        "General Internal Medicine, VA Medical Center": "44.98 -93.264"
    }
}